Pemphigus vulgaris (pemphigoid) is a rare autoimmune disease characterized by the formation of blisters on the skin and mucous membranes. The main mechanism of pathogenesis is the production of antibodies to the components of the basement membrane, which leads to its damage and the development of blisters filled with turbid exudate. The disease can manifest itself as both localized and generalized blisters, which makes its clinical course diverse. Pemphigus vulgaris is most often observed in older people, but the disease can also develop at a younger age. The mechanisms of the formation of an autoimmune response have not been fully studied, but it is believed that both genetic and external factors can play a role among the risk factors.
History of the disease and interesting historical facts
Pemphigus vulgaris was first described in medical literature in the 19th century. One of the first clinicians to study the disease was the German dermatologist Friedrich Hebra, who described the clinical and histopathological features of the disease in 1866. Over the next decades, research into pemphigus vulgaris continued, and experience in diagnosing and treating the disease gradually accumulated. In 1953, the American dermatologist D.S. Reddy was the first to propose the concept of an autoimmune mechanism, which later became the basis for modern understanding of the pathogenesis of the disease. Interestingly, the blisters that occur with pemphigus vulgaris are clearly demonstrated on skin samples, which in itself has become a classic example for teaching medical specialties.
Epidemiology
Pemphigus vulgaris is a relatively rare disease, with incidence varying by geographic region and ethnicity. Current estimates range from 0.1 to 5 cases per 100,000 people per year. The incidence varies among populations, which may be due to genetic and environmental factors. In most cases, the disease begins between the ages of 60 and 80, and is more common in women than in men. It is also worth noting that there has been an increase in the number of cases in recent decades, which may be due to improved diagnostics and increased life expectancy.
Genetic predisposition to this disease
There is evidence of a significant role of genetic factors in the development of pemphigus vulgaris. Studies have shown that certain HLA (histocompatibility) alleles can increase the risk of developing this disease. In particular, associated genes such as HLA-DR4 and HLA-DQ7 were associated with an increased susceptibility to the formation of an autoimmune response. In addition, studies have identified mutations in genes encoding basement membrane proteins such as collagen IV. The presence of such mutations can contribute to damage to cell flagella and, as a result, to the formation of blisters. However, despite the discovered genetic associations, a single genetic risk factor cannot be determined, which emphasizes the polyetiological nature of the disease.
Risk factors for the development of this disease
Risk factors that contribute to the development of pemphigus vulgaris include:
- Age: The incidence increases with age, especially after 60 years.
- Gender: Women are more susceptible to the disease than men.
- Autoimmune diseases: Having other autoimmune diseases, such as lupus or thyroiditis, may increase your risk.
- Drug effects: Some medications, including antibiotics and blood pressure medications, can trigger autoimmune reactions.
- Environmental factors: Exposure to sunlight and other physical factors may also play a role in pathogenesis.
Diagnosis of this disease
Diagnosis of pemphigus vulgaris requires a comprehensive approach, including clinical and laboratory tests. The main symptoms include:
- The appearance of blisters on the skin, which may be painful or itchy.
- Lesions of the mucous membranes, such as the oral cavity.
- Absence of inflammatory changes in the area of the blisters.
Laboratory tests include:
- Immunofluorescence assay for detection of specific autoantibodies.
- Histological examination of a skin biopsy showing detachment of the superficial layer of the epidermis.
Radiological examinations are not used in diagnosis, but may be useful to exclude other diseases. It is important to conduct differential diagnosis with other systemic and dermatological diseases, such as bullous pemphigoid and leukemic conditions.
Treatment
Treatment of pemphigus vulgaris should be aimed at controlling symptoms and suppressing the autoimmune response. General treatment includes following a soft diet and caring for the affected skin. Pharmacological therapy most often includes corticosteroids, such as prednisolone, which help reduce inflammation and the autoimmune process. In severe cases, immunosuppressants, such as azathioprine and rituximab, may be prescribed. Surgery may be required for complications, such as secondary bacterial infection. Various procedures, including dermatoplasty, are sometimes used in cases of severe lesions.
List of medications used to treat this disease
- Prednisolone
- Azathioprine
- Rituximab
- Dexamethasone
- Bendamustine
Disease monitoring
Monitoring the progress of the disease includes regular visits to a dermatologist and monitoring the level of autoantibodies in the blood. The prognosis of the disease is generally favorable with timely and appropriate treatment. However, some patients may experience relapses, which requires adjustment of therapy. Complications such as secondary infection of skin blisters or systemic autoimmune processes may also be observed and require careful monitoring.
Age-related features of the disease
Pemphigus vulgaris manifests itself differently in different age groups. In older patients, the disease often begins with more pronounced blisters and difficulties in treatment. In younger patients, the disease may manifest itself with less pronounced symptoms, but requires careful monitoring, as it can proceed more aggressively. In addition, in children, special attention is paid to possible long-term consequences and the psycho-emotional state in connection with ongoing treatment.
Questions and Answers
- What are the main symptoms of pemphigus vulgaris? The main manifestation is the appearance of blisters on the skin and mucous membranes, which can be painful and itchy, and the absence of inflammatory changes in the area of the blisters.
- How is pemphigus vulgaris diagnosed? Diagnosis includes clinical examination, laboratory tests, immunofluorescence and histological examination of skin samples.
- Is it possible to cure pemphigus vulgaris completely? A complete cure is not always possible, but modern treatment can achieve long-term remission and control of symptoms.
- Is there a risk of recurrence of the disease? Yes, relapses may occur, especially if therapy is stopped unjustifiably.
- What is the role of genetic predisposition in the development of the disease? Genetic factors such as HLA alleles may increase the risk of developing pemphigus vulgaris, but are not the only factor.
